WST
West Pharmaceutical Services Inc
Price:  
325.68 
USD
Volume:  
305,787.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

WST WACC - Weighted Average Cost of Capital

The WACC of West Pharmaceutical Services Inc (WST) is 7.6%.

The Cost of Equity of West Pharmaceutical Services Inc (WST) is 7.70%.
The Cost of Debt of West Pharmaceutical Services Inc (WST) is 4.25%.

Range Selected
Cost of equity 6.50% - 8.90% 7.70%
Tax rate 17.60% - 17.90% 17.75%
Cost of debt 4.00% - 4.50% 4.25%
WACC 6.4% - 8.9% 7.6%
WACC

WST WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.57 0.72
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 8.90%
Tax rate 17.60% 17.90%
Debt/Equity ratio 0.01 0.01
Cost of debt 4.00% 4.50%
After-tax WACC 6.4% 8.9%
Selected WACC 7.6%